CN113367692B - Adjusting method, adjusting system and storage medium capable of adjusting blood sugar of user - Google Patents
Adjusting method, adjusting system and storage medium capable of adjusting blood sugar of user Download PDFInfo
- Publication number
- CN113367692B CN113367692B CN202110638034.3A CN202110638034A CN113367692B CN 113367692 B CN113367692 B CN 113367692B CN 202110638034 A CN202110638034 A CN 202110638034A CN 113367692 B CN113367692 B CN 113367692B
- Authority
- CN
- China
- Prior art keywords
- value
- blood glucose
- main control
- control unit
- user
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000008280 blood Substances 0.000 title claims abstract description 258
- 210000004369 blood Anatomy 0.000 title claims abstract description 258
- 238000000034 method Methods 0.000 title claims abstract description 40
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims abstract description 162
- 239000008103 glucose Substances 0.000 claims abstract description 162
- 230000033764 rhythmic process Effects 0.000 claims abstract description 16
- 230000008451 emotion Effects 0.000 claims abstract description 9
- 230000001105 regulatory effect Effects 0.000 claims description 38
- 238000005286 illumination Methods 0.000 claims description 23
- 238000001514 detection method Methods 0.000 claims description 14
- 238000004590 computer program Methods 0.000 claims description 3
- 238000001228 spectrum Methods 0.000 claims description 3
- 230000007613 environmental effect Effects 0.000 description 10
- 230000007423 decrease Effects 0.000 description 8
- 230000004060 metabolic process Effects 0.000 description 5
- 230000002159 abnormal effect Effects 0.000 description 4
- 230000001419 dependent effect Effects 0.000 description 4
- 230000005856 abnormality Effects 0.000 description 3
- 238000004378 air conditioning Methods 0.000 description 3
- 230000002996 emotional effect Effects 0.000 description 3
- 210000003205 muscle Anatomy 0.000 description 3
- 238000006243 chemical reaction Methods 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 230000004190 glucose uptake Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 230000003595 spectral effect Effects 0.000 description 2
- UCTWMZQNUQWSLP-VIFPVBQESA-N (R)-adrenaline Chemical compound CNC[C@H](O)C1=CC=C(O)C(O)=C1 UCTWMZQNUQWSLP-VIFPVBQESA-N 0.000 description 1
- 229930182837 (R)-adrenaline Natural products 0.000 description 1
- 229920002527 Glycogen Polymers 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 229960005139 epinephrine Drugs 0.000 description 1
- 229940096919 glycogen Drugs 0.000 description 1
- 230000005802 health problem Effects 0.000 description 1
- 230000002440 hepatic effect Effects 0.000 description 1
- 230000004089 microcirculation Effects 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 210000003491 skin Anatomy 0.000 description 1
- 238000010183 spectrum analysis Methods 0.000 description 1
- 230000000087 stabilizing effect Effects 0.000 description 1
- 238000007920 subcutaneous administration Methods 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
- A61B5/1455—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue using optical sensors, e.g. spectral photometrical oximeters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
- A61B5/14532—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue for measuring glucose, e.g. by tissue impedance measurement
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/72—Signal processing specially adapted for physiological signals or for diagnostic purposes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/74—Details of notification to user or communication with user or patient ; user input means
- A61B5/746—Alarms related to a physiological condition, e.g. details of setting alarm thresholds or avoiding false alarms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M21/00—Other devices or methods to cause a change in the state of consciousness; Devices for producing or ending sleep by mechanical, optical, or acoustical means, e.g. for hypnosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M21/00—Other devices or methods to cause a change in the state of consciousness; Devices for producing or ending sleep by mechanical, optical, or acoustical means, e.g. for hypnosis
- A61M21/02—Other devices or methods to cause a change in the state of consciousness; Devices for producing or ending sleep by mechanical, optical, or acoustical means, e.g. for hypnosis for inducing sleep or relaxation, e.g. by direct nerve stimulation, hypnosis, analgesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/06—Radiation therapy using light
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/06—Radiation therapy using light
- A61N5/0613—Apparatus adapted for a specific treatment
-
- F—MECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
- F24—HEATING; RANGES; VENTILATING
- F24F—AIR-CONDITIONING; AIR-HUMIDIFICATION; VENTILATION; USE OF AIR CURRENTS FOR SCREENING
- F24F11/00—Control or safety arrangements
- F24F11/89—Arrangement or mounting of control or safety devices
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/06—Radiation therapy using light
- A61N2005/0658—Radiation therapy using light characterised by the wavelength of light used
- A61N2005/0659—Radiation therapy using light characterised by the wavelength of light used infrared
- A61N2005/066—Radiation therapy using light characterised by the wavelength of light used infrared far infrared
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/06—Radiation therapy using light
- A61N2005/0658—Radiation therapy using light characterised by the wavelength of light used
- A61N2005/0661—Radiation therapy using light characterised by the wavelength of light used ultraviolet
Abstract
The application discloses a method, a system and a storage medium for adjusting blood sugar of an adjustable user, wherein the main flow of the method for adjusting the blood sugar of the adjustable user is as follows: the method comprises the steps that a main control unit establishes a first comparison curve, wherein the value on the abscissa axis of the first comparison curve is a blood sugar value, and the value on the ordinate axis of the first comparison curve is a temperature value; the main control unit acquires a group of blood glucose data every 10 minutes; the main control unit performs weighted average processing on the blood glucose data to obtain a real-time blood glucose value; if the real-time blood glucose value is smaller than the preset blood glucose value, the main control unit acquires a corresponding temperature value on the first comparison curve according to the real-time blood glucose value, and takes the acquired temperature value as the first comparison value; the main control unit adjusts the temperature in the environment according to the first comparison value; and adjusting the ambient temperature according to the change of the real-time blood glucose value of the user, guiding the blood glucose value to restore the normal state through the ambient temperature, and restoring the emotion and life rhythm of the user to the normal state.
Description
Technical Field
The application relates to the technical field of intelligent home, in particular to a method and a system for adjusting blood sugar of a user and a storage medium.
Background
Environmental factors have great influence on emotion health and life rhythm, blood sugar is one of important reference data for determining whether human body is healthy or not, and can reflect the emotion health problem and life rhythm problem of the human body.
It can be seen that there is a need for improvements and improvements in the art.
Disclosure of Invention
In view of the above-mentioned shortcomings of the prior art, an object of the present application is to provide a method, a system and a storage medium for adjusting blood glucose of a user, which can adjust the environmental temperature according to the change of blood glucose, guide the blood glucose level to return to a normal state through the environmental temperature, and send out an alarm in time if the blood glucose level is found to be severely beyond the upper limit blood glucose level.
In order to achieve the above purpose, the application adopts the following technical scheme:
an adjusting method capable of adjusting blood sugar of a user specifically comprises the following steps:
the method comprises the steps that a main control unit establishes a first comparison curve, wherein the value on the abscissa axis of the first comparison curve is a blood sugar value, and the value on the ordinate axis of the first comparison curve is a temperature value;
the main control unit acquires a group of blood glucose data every 10 minutes;
the main control unit performs weighted average processing on the blood glucose data to obtain a real-time blood glucose value;
if the real-time blood glucose value is smaller than the preset blood glucose value, the main control unit acquires a corresponding temperature value on the first comparison curve according to the real-time blood glucose value, and takes the acquired temperature value as the first comparison value;
the main control unit adjusts the temperature in the environment according to the first comparison value.
The method for adjusting the blood sugar of the user comprises the following steps:
the main control unit acquires a second comparison curve, wherein the value on the abscissa axis of the second comparison curve is a blood sugar value, and the value on the ordinate axis of the second comparison curve is an ultraviolet illumination value;
the main control unit acquires a group of blood glucose data every 10 minutes;
the main control unit performs weighted average processing on the blood glucose data to obtain a real-time blood glucose value;
if the real-time blood glucose value is smaller than the preset blood glucose value, the main control unit acquires a corresponding ultraviolet illuminance value on the second comparison curve according to the real-time blood glucose value, and takes the acquired ultraviolet illuminance value as the second comparison value;
and the main control unit adjusts the ultraviolet illumination in the environment according to the second comparison value.
The method for adjusting the blood sugar of the user comprises the following steps:
the main control unit acquires a third comparison curve, wherein the value on the abscissa axis of the third comparison curve is a blood sugar value, and the value on the ordinate axis of the third comparison curve is a far infrared light illuminance value;
the main control unit acquires a group of blood glucose data every 10 minutes;
the main control unit performs weighted average processing on the blood glucose data to obtain a real-time blood glucose value;
if the real-time blood glucose value is smaller than the preset blood glucose value, the main control unit acquires a corresponding far infrared light illuminance value on a third comparison curve according to the real-time blood glucose value, and takes the acquired temperature value as the third comparison value;
the main control unit adjusts far infrared illumination in the environment according to the third comparison value.
In the method for adjusting the blood sugar of the user, if the real-time blood sugar value is smaller than the preset blood sugar value, the main control unit obtains a corresponding temperature value on the first comparison curve according to the real-time blood sugar value, and takes the obtained temperature value as the first comparison value, and the method specifically further comprises:
if the real-time blood glucose value is larger than the preset blood glucose value, the main control unit sends out an alarm signal.
In the method for adjusting the blood sugar of the user, the main control unit acquires a first comparison curve, wherein the value on the abscissa axis of the first comparison curve is a blood sugar value, and the value on the ordinate axis of the first comparison curve is a temperature value, and the method specifically further comprises:
the main control unit acquires a working origin of the abscissa axis according to the normal blood sugar value of the user;
the main control unit obtains the working origin of the ordinate axis according to the temperature value of the user when the user is at the normal blood sugar value.
In the method for adjusting the blood sugar of the user, the main control unit acquires a second comparison curve, wherein the value on the abscissa axis of the second comparison curve is a blood sugar value, and the value on the ordinate axis of the second comparison curve is an ultraviolet illuminance value, and the method specifically further comprises:
the main control unit acquires a working origin of the abscissa axis according to the normal blood sugar value of the user;
the main control unit obtains the working origin of the ordinate axis according to the ultraviolet illuminance value when the user is at the normal blood sugar value.
In the method for adjusting the blood sugar of the user, the main control unit acquires a third comparison curve, wherein the value on the abscissa axis of the third comparison curve is a blood sugar value, and the value on the ordinate axis of the third comparison curve is a far infrared illumination value, and the method specifically further comprises:
the main control unit acquires a working origin of the abscissa axis according to the normal blood sugar value of the user;
the main control unit obtains the working origin of the ordinate axis according to the far infrared illumination value when the user is at the normal blood sugar value.
The application also provides a regulating system for regulating the blood sugar of the user, which realizes work control by adopting the regulating method for regulating the blood sugar of the user, and comprises a main control unit, a detection unit and an output regulating unit, wherein the detection unit and the output regulating unit are respectively connected with the main control unit; the detection unit is used for acquiring the real-time blood glucose value of the user, and the output adjusting unit is used for adjusting the temperature, the ultraviolet light illuminance and the far infrared light illuminance.
In the blood sugar regulating system for regulating the blood sugar of the user, the detection unit is an infrared sensor, and the infrared sensor is used for collecting blood sugar characteristic spectrum signals.
The present application also provides a computer readable storage medium storing a computer program which, when executed by a processor, causes the processor to perform the method of regulating blood glucose of an adjustable user as described above.
The beneficial effects are that:
the application provides a regulating method capable of regulating the blood sugar of a user, which regulates the ambient temperature according to the change of the blood sugar value of the user in real time, guides the blood sugar value to recover to a normal state through the ambient temperature, and enables the emotion and life rhythm of the user to recover to the normal state.
Drawings
FIG. 1 is a control flow chart I of a method for regulating blood glucose of a user according to the present application;
FIG. 2 is a second control flow chart of the method for regulating blood glucose of a user according to the present application;
FIG. 3 is a control flow chart III of the method for regulating blood glucose of a user according to the present application;
fig. 4 is a schematic flow chart of step S110 in the method for adjusting blood glucose of a user according to the present application;
fig. 5 is a schematic flow chart of step S120 in the method for adjusting blood glucose of a user according to the present application;
fig. 6 is a schematic flow chart of step S130 in the method for adjusting blood glucose of a user according to the present application;
fig. 7 is a system block diagram of a system for regulating blood glucose of a user according to the present application.
Description of main reference numerals: 1-main control unit, 2-detecting element, 3-output regulating element.
Detailed Description
The application provides a method, a system and a storage medium for adjusting blood sugar of a user, which are used for making the purposes, technical schemes and effects of the application clearer and more definite, and the application is further described in detail below by referring to the accompanying drawings and examples. It should be understood that the detailed description and specific examples are intended for purposes of illustration only and are not intended to limit the scope of the application.
In the description of the present application, it should be understood that the terms "first," "second," "third," and the like are used for descriptive purposes only and are not to be construed as indicating or implying relative importance or implicitly indicating the number of technical features indicated, the specific meaning of the above terms in the present application being understood by one of ordinary skill in the art in light of the specific circumstances.
Referring to fig. 1 to 7, the present application provides a method for adjusting blood sugar of a user, which specifically includes the following steps:
s110, the main control unit establishes a first comparison curve, wherein the value on the abscissa axis of the first comparison curve is a blood sugar value, and the value on the ordinate axis of the first comparison curve is a temperature value; blood glucose values are used as independent variables of a coordinate system, temperature values are used as dependent variables of the coordinate system, blood glucose values and the like are distributed on the abscissa axis, and each blood glucose value corresponds to one temperature value.
In one embodiment, when the blood glucose level is used as an independent variable and the temperature level is used as a dependent variable, the temperature level increases with an increase in the blood glucose level, and in actual use, if the blood glucose level of the user increases, the temperature level increases, and when the temperature level increases, the metabolism rate in the user increases, and thus the glucose uptake amount by the muscle increases, and the blood glucose level decreases, and if the blood glucose level of the user decreases, the temperature level decreases, and when the temperature level decreases, the user receives a cold stimulus, and thus the epinephrine secretion is promoted, and the hepatic glycogen output increases, and thus the glucose uptake amount by the muscle decreases, even if the blood glucose level increases. The environmental temperature is regulated according to the blood sugar value of the user, so that the blood sugar value of the user is led to gradually trend to the health level.
S120, the main control unit acquires a second comparison curve, wherein the value on the abscissa axis of the second comparison curve is a blood sugar value, and the value on the ordinate axis of the second comparison curve is an ultraviolet illumination value; blood glucose values are used as independent variables of a coordinate system, ultraviolet light illuminance values are used as independent variables of the coordinate system, blood glucose values and the like are distributed on the abscissa axis, and each blood glucose value corresponds to one ultraviolet light illuminance value.
In one embodiment, when the blood glucose level is taken as an independent variable and the ultraviolet illuminance value is taken as a dependent variable, the ultraviolet illuminance value is increased along with the increase of the blood glucose level, and in practical application, if the blood glucose level of a user is increased, the ultraviolet illuminance of the environment is enhanced by adjusting the ultraviolet illuminance value, the physiological balance of the user is assisted, the microcirculation is improved, the blood oxygen saturation is increased, so that the metabolism speed in the user is increased, the blood glucose is reduced, and if the blood glucose of the user is reduced, the ultraviolet illuminance of the environment is reduced by adjusting the ultraviolet illuminance value, so that the metabolism speed in the user is reduced, and the blood glucose level of the user is gradually increased.
S130, the main control unit acquires a third comparison curve, wherein the value on the abscissa axis of the third comparison curve is a blood sugar value, and the value on the ordinate axis of the third comparison curve is a far infrared illumination value; the blood glucose values are used as independent variables of a coordinate system, the far infrared light illuminance values are used as independent variables of the coordinate system, the blood glucose values are distributed on the abscissa axis in an equal difference mode, and each blood glucose value corresponds to one far infrared light illuminance value.
In one embodiment, when the blood glucose level is used as an independent variable and the far-infrared illuminance is used as a dependent variable, the far-infrared illuminance value increases with the increase of the blood glucose level, and in actual application, if the blood glucose level of the user increases, the far-infrared illuminance of the environment increases, the subcutaneous blood circulation of the user is promoted by the far-infrared light, the metabolism speed increases, and thus the blood glucose level of the user is reduced, and if the blood glucose of the user decreases, the far-infrared illuminance value of the environment decreases, and the metabolism speed in the user decreases, thereby increasing the blood glucose level of the user.
Further, the step S110 of the main control unit establishing a first comparison curve, wherein the value on the abscissa axis of the first comparison curve is a blood glucose value, and the value on the ordinate axis of the first comparison curve is a temperature value, and specifically further includes:
s111, the main control unit acquires a working origin of an abscissa axis according to a normal blood sugar value of a user; the working origin of the axis of abscissa is set according to the normal blood sugar values of different users in health states, so that the main control unit can pertinently regulate the life rhythm of a certain user, and the blood sugar value of the user is always kept on the working origin of the axis of abscissa by regulating the surrounding environment of the user, so that the user keeps the physiological rhythm of emotional health and normal.
S112, the main control unit acquires the working origin of the ordinate axis according to the temperature value of the user when the user is at the normal blood sugar value; by setting the working origin of the temperature on the ordinate axis, a reference system is provided for the main control unit to adjust the environment, and the temperature value of the user at the normal blood sugar value can be judged.
Further, the step S120 of the main control unit obtaining a second comparison curve, where the value on the abscissa axis of the second comparison curve is a blood glucose value, and the value on the ordinate axis of the second comparison curve is an ultraviolet illuminance value, specifically further includes:
s121, the main control unit acquires a working origin of an abscissa axis according to a normal blood sugar value of a user; the working origin of the axis of abscissa is set according to the normal blood sugar values of different users in health states, so that the main control unit can pertinently regulate the life rhythm of a certain user, and the blood sugar value of the user is always kept on the working origin of the axis of abscissa by regulating the surrounding environment of the user, so that the user keeps the physiological rhythm of emotional health and normal.
S122, the main control unit acquires a working origin of the ordinate axis according to the ultraviolet illuminance value when the user is at the normal blood sugar value; the ultraviolet illuminance value of the user at the normal blood sugar value can be judged by setting the working origin of the ultraviolet illuminance value on the ordinate axis and providing a reference system for the main control unit when the main control unit adjusts the environment.
Further, the step S130 of the main control unit obtaining a third comparison curve, where the value on the abscissa axis of the third comparison curve is a blood glucose value, and the value on the ordinate axis of the second comparison curve is a far infrared illuminance value, specifically further includes:
s131, the main control unit acquires a working origin of an abscissa axis according to the normal blood sugar value of a user; the working origin of the axis of abscissa is set according to the normal blood sugar values of different users in health states, so that the main control unit can pertinently regulate the life rhythm of a certain user, and the blood sugar value of the user is always kept on the working origin of the axis of abscissa by regulating the surrounding environment of the user, so that the user keeps the physiological rhythm of emotional health and normal.
S132, the main control unit acquires a working origin of the ordinate axis according to the far infrared illuminance value when the user is at the normal blood sugar value; by setting the working origin of the far infrared illuminance value on the ordinate axis, a reference system is provided for the main control unit to adjust the environment, and the far infrared illuminance value of the user in the normal blood sugar value can be judged.
Wherein the normal blood glucose level is in the range of 3.9 to 6.1mmol/L. In this embodiment, the normal blood glucose level may be 5.0mmol/L.
Further, S210, the main control unit acquires a group of blood glucose data every 10 minutes; the blood sugar data of the user are obtained every 5 to 10 minutes, so that the excessive frequency of the main control unit for adjusting the environment is avoided, and the effect of adjusting the emotion and life rhythm of the user is influenced; if a group of blood sugar data is obtained every 1 minute, namely the environment is changed every minute, the human body cannot better adapt to the environment change in a short time, and the human body cannot play a role in stabilizing emotion and life rhythm in the environment with quicker frequency conversion, and even can generate a reaction, so that the fluctuation of the emotion and life rhythm is increased.
S310, the main control unit performs weighted average processing on the blood glucose data to obtain a real-time blood glucose value; the blood glucose value measured within 10 minutes is subjected to average value processing, so that the real-time blood glucose value is obtained, the accuracy of the real-time blood glucose value of a user within any time period is improved, and the temperature, the ultraviolet light illumination and the far infrared light illumination are more accurately regulated.
Among them, step S220 and step S210 coincide with step S210, and step S320 and step S330 coincide with step S310.
Further, if the real-time blood glucose level is smaller than the preset blood glucose level in step S510, the main control unit obtains a corresponding temperature value on the first control curve according to the real-time blood glucose level, and takes the obtained temperature value as the first control value, and specifically further includes:
s410, if the real-time blood glucose value is larger than the preset blood glucose value, the main control unit sends out an alarm signal; in this embodiment, the preset blood glucose level may be 11.1mmol/L; the preset blood sugar value is the upper limit value of abnormal blood sugar, if the real-time blood sugar value of the user exceeds the preset blood sugar value, the problem that the user is possibly life-threatening is indicated, and therefore the main control unit immediately sends out an alarm signal after judging that the real-time blood sugar value of the user exceeds the preset blood sugar value.
Step S420 and step S410 correspond to step S410.
Further, if the real-time blood glucose level is smaller than the preset blood glucose level, the main control unit obtains a corresponding temperature value on the first control curve according to the real-time blood glucose level, and takes the obtained temperature value as the first control value.
S610, the main control unit adjusts the temperature value in the environment according to the first comparison value.
If the real-time blood glucose level is smaller than the preset blood glucose level, it indicates that the blood glucose level of the user is in an abnormal state and does not exceed the upper limit value of the blood glucose abnormality, and the blood glucose level can be guided to be restored to be stable by adjusting the ambient temperature, the main control unit obtains coordinate data corresponding to the first contrast curve according to the real-time blood glucose level, takes the ordinate value in the coordinate data as the first contrast value, and sends a control signal to external equipment according to the first contrast value, for example, but not limited to: an air conditioning device to regulate the temperature in the environment to guide the user to a stable blood glucose level.
And S520, if the real-time blood glucose value is smaller than the preset blood glucose value, the main control unit acquires a corresponding ultraviolet illuminance value on the second comparison curve according to the real-time blood glucose value, and takes the acquired ultraviolet illuminance value as the second comparison value.
S620, the main control unit adjusts the ultraviolet illumination in the environment according to the second comparison value.
If the real-time blood glucose level is smaller than the preset blood glucose level, it indicates that the blood glucose level of the user is in an abnormal state and does not exceed the upper limit value of the blood glucose abnormality, and the blood glucose level can be guided to be restored to be stable by adjusting the illuminance of the ultraviolet light of the environment, the main control unit obtains coordinate data corresponding to the second comparison curve according to the real-time blood glucose level, takes the ordinate value in the coordinate data as the second comparison value, and the main control unit sends a control signal to external equipment according to the second comparison value, for example, but not limited to: and an ultraviolet lighting device, so as to adjust the ultraviolet illumination in the environment to guide the user to reach a stable blood sugar value.
Further, S530, if the real-time blood glucose level is smaller than the preset blood glucose level, the main control unit obtains a corresponding far-infrared illuminance value on the third control curve according to the real-time blood glucose level, and takes the obtained temperature value as the third control value.
S630, the main control unit adjusts far infrared illumination in the environment according to the third comparison value.
If the real-time blood glucose level is smaller than the preset blood glucose level, it indicates that the blood glucose level of the user is in an abnormal state and does not exceed the upper limit value of the blood glucose abnormality, and the blood glucose level can be guided to be restored to be stable by adjusting the far infrared illuminance of the environment, the main control unit obtains coordinate data corresponding to the third comparison curve according to the real-time blood glucose level, takes the ordinate value in the coordinate data as the third comparison value, and sends a control signal to the external device according to the third comparison value, for example, but not limited to: a far infrared light illumination device to adjust the far infrared light illuminance in the environment to guide the user to reach a stable blood glucose value.
In summary, the environmental temperature, the environmental ultraviolet illuminance and the environmental far infrared illuminance are adjusted according to the change of the real-time blood glucose level of the user, and the blood glucose level is guided to be recovered to the normal state through the environmental temperature, the environmental ultraviolet illuminance and the environmental far infrared illuminance, so that the emotion and the life rhythm of the user are recovered to the normal state, and in addition, if the blood glucose level is found to be seriously beyond the upper limit blood glucose level, an alarm can be sent out in time.
The application also provides a regulating system for regulating the blood sugar of the user, which realizes work control by adopting the regulating method for regulating the blood sugar of the user, as shown in figure 7, wherein the regulating system for regulating the blood sugar of the user comprises a main control unit 1, a detection unit 2 and an output regulating unit 3, and the detection unit 2 and the output regulating unit 3 are respectively connected with the main control unit 1; the detection unit 2 is used for acquiring a real-time blood glucose value of a user, and the output adjusting unit 3 is used for adjusting a temperature value, an ultraviolet illuminance value and a far infrared illuminance value; the output adjusting unit 3 is connected with an air conditioning device, an ultraviolet lighting device and a far infrared lighting device; the main control unit 1 respectively establishes a first control curve, a second control curve and a third control curve with the normal blood sugar value of the user according to the temperature value, the ultraviolet illuminance value and the far infrared illuminance value when the user is at the normal blood sugar value; the detection unit 2 detects the blood sugar value of the user in real time to obtain the real-time blood sugar value of the user, the real-time blood sugar value of the user is sent to the main control unit 1, the main control unit 1 respectively obtains a first comparison value, a second comparison value and a third comparison value according to the real-time blood sugar value, the first comparison value, the second comparison value and the third comparison value are used as reference quantities for regulating the temperature value, the ultraviolet illumination value and the far infrared illumination value, the main control unit 1 finally converts the reference quantities into control signals and outputs the control signals to the output regulating unit 3, and the output regulating unit 3 controls the air conditioning equipment, the ultraviolet illumination equipment and the far infrared illumination equipment according to the control signals so as to regulate the temperature value, the ultraviolet illumination value and the far infrared illumination value, change the environment, guide the blood sugar value of the user to be stable and restore to the normal blood sugar value.
Further, the detection unit 2 is an infrared sensor, and the infrared sensor is used for collecting blood glucose characteristic spectrum signals; extracting blood glucose values through spectral analysis of near infrared rays, middle infrared rays or far infrared rays by a human body, when the human body is irradiated with infrared rays, human tissues irrelevant to blood glucose, such as skin, bones, muscles, water and the like, absorb most of the infrared rays, and reflect or absorb infrared rays representing blood glucose characteristics in a small amount, so that blood glucose characteristic spectral signals are remained, and extracting the blood glucose values according to the blood glucose characteristic spectral signal analysis; in this embodiment, the detection unit 2 and the main control unit 1 may be connected wirelessly, such as, but not limited to, bluetooth connection, wi-Fi connection.
The present application also provides a computer readable storage medium storing a computer program which, when executed by a processor, causes the processor to perform the method of regulating blood glucose of an adjustable user as described above.
It will be understood that equivalents and modifications will occur to those skilled in the art based on the present application and its spirit, and all such modifications and substitutions are intended to be included within the scope of the present application.
Claims (8)
1. A method for regulating blood glucose in a user, comprising the steps of: the method comprises the steps that a main control unit establishes a first comparison curve, wherein the value on the abscissa axis of the first comparison curve is a blood sugar value, and the value on the ordinate axis of the first comparison curve is a temperature value; the main control unit acquires a group of blood glucose data every 10 minutes;
the main control unit performs weighted average processing on the blood glucose data to obtain a real-time blood glucose value; if the real-time blood glucose value is smaller than the preset blood glucose value, the main control unit acquires a corresponding temperature value on the first comparison curve according to the real-time blood glucose value, and takes the acquired temperature value as the first comparison value; the main control unit adjusts the temperature in the environment according to the first comparison value;
if the real-time blood glucose level is smaller than the preset blood glucose level, the main control unit obtains a corresponding temperature value on the first comparison curve according to the real-time blood glucose level, and takes the obtained temperature value as the first comparison value, and specifically further comprises: if the real-time blood glucose value is larger than the preset blood glucose value, the main control unit sends out an alarm signal; the main control unit obtains a first comparison curve, wherein the value on the abscissa axis of the first comparison curve is a blood sugar value, and the value on the ordinate axis of the first comparison curve is a temperature value, and the main control unit specifically further comprises: the main control unit acquires a working origin of the abscissa axis according to the normal blood sugar value of the user; the main control unit acquires the working origin of the ordinate axis according to the temperature value of the user when the user is at the normal blood sugar value;
setting the working origin of the abscissa axis according to the normal blood sugar values of different users in the health state, so that the main control unit can pertinently regulate the life rhythm of a certain user, and the blood sugar value of the user is always kept on the working origin of the abscissa axis by regulating the surrounding environment of the user, so that the user keeps the physiological rhythm of the emotion health and normal; by setting the working origin of the temperature on the ordinate axis, a reference system is provided for the main control unit to adjust the environment, and the temperature value of the user at the normal blood sugar value can be judged.
2. The method for regulating blood glucose of an adjustable user according to claim 1, further comprising the steps of: the main control unit acquires a second comparison curve, wherein the value on the abscissa axis of the second comparison curve is a blood sugar value, and the value on the ordinate axis of the second comparison curve is an ultraviolet illumination value; the main control unit acquires a group of blood glucose data every 10 minutes; the main control unit performs weighted average processing on the blood glucose data to obtain a real-time blood glucose value; if the real-time blood glucose value is smaller than the preset blood glucose value, the main control unit acquires a corresponding ultraviolet illuminance value on the second comparison curve according to the real-time blood glucose value, and takes the acquired ultraviolet illuminance value as the second comparison value; and the main control unit adjusts the ultraviolet illumination in the environment according to the second comparison value.
3. The method for regulating blood glucose of an adjustable user according to claim 1, further comprising the steps of: the main control unit acquires a third comparison curve, wherein the value on the abscissa axis of the third comparison curve is a blood sugar value, and the value on the ordinate axis of the third comparison curve is a far infrared light illuminance value; the main control unit acquires a group of blood glucose data every 10 minutes; the main control unit performs weighted average processing on the blood glucose data to obtain a real-time blood glucose value; if the real-time blood glucose value is smaller than the preset blood glucose value, the main control unit acquires a corresponding far infrared light illuminance value on a third comparison curve according to the real-time blood glucose value, and takes the acquired temperature value as the third comparison value; the main control unit adjusts far infrared illumination in the environment according to the third comparison value.
4. The method for adjusting blood glucose of an adjustable user according to claim 2, wherein the main control unit obtains a second comparison curve, the value on the abscissa axis of the second comparison curve is a blood glucose value, and the value on the ordinate axis of the second comparison curve is an ultraviolet illuminance value, and specifically further comprises: the main control unit acquires a working origin of the abscissa axis according to the normal blood sugar value of the user; the main control unit obtains the working origin of the ordinate axis according to the ultraviolet illuminance value when the user is at the normal blood sugar value.
5. The method for adjusting blood glucose of an adjustable user according to claim 3, wherein the main control unit obtains a third comparison curve, the value on the abscissa axis of the third comparison curve is a blood glucose value, and the value on the ordinate axis of the third comparison curve is a far infrared illuminance value, and specifically further comprises: the main control unit acquires a working origin of the abscissa axis according to the normal blood sugar value of the user; the main control unit obtains the working origin of the ordinate axis according to the far infrared illumination value when the user is at the normal blood sugar value.
6. The system for adjusting the blood sugar of the user is characterized in that the system for adjusting the blood sugar of the user realizes work control by adopting the method for adjusting the blood sugar of the user according to any one of claims 1-5, and comprises a main control unit, a detection unit and an output adjusting unit, wherein the detection unit and the output adjusting unit are respectively connected with the main control unit; the detection unit is used for acquiring the real-time blood glucose value of the user, and the output adjusting unit is used for adjusting the temperature, the ultraviolet light illuminance and the far infrared light illuminance.
7. The adjustable user blood glucose regulation system of claim 6, wherein the detection unit is an infrared sensor for acquiring a blood glucose signature spectrum signal.
8. A computer readable storage medium, characterized in that the computer readable storage medium stores a computer program which, when executed by a processor, causes the processor to perform the method of regulating blood glucose of an adjustable user according to any one of claims 1-5.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202110638034.3A CN113367692B (en) | 2021-06-08 | 2021-06-08 | Adjusting method, adjusting system and storage medium capable of adjusting blood sugar of user |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202110638034.3A CN113367692B (en) | 2021-06-08 | 2021-06-08 | Adjusting method, adjusting system and storage medium capable of adjusting blood sugar of user |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN113367692A CN113367692A (en) | 2021-09-10 |
| CN113367692B true CN113367692B (en) | 2023-09-29 |
Family
ID=77576559
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202110638034.3A Active CN113367692B (en) | 2021-06-08 | 2021-06-08 | Adjusting method, adjusting system and storage medium capable of adjusting blood sugar of user |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN113367692B (en) |
Citations (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2005110222A1 (en) * | 2004-05-18 | 2005-11-24 | Okto Medical Appliance Co., Ltd. | Blood sugar control system and medical treatment method using the same |
| CN1775174A (en) * | 2005-11-28 | 2006-05-24 | 何宗彦 | Non-wound rapid blood sugar detecting method and its detecting instrument |
| KR101320555B1 (en) * | 2012-05-09 | 2013-11-06 | (주)세종바이오테크놀로지 | System for measuring blood sugar level |
| CN203455308U (en) * | 2013-07-29 | 2014-02-26 | 深圳市倍泰健康测量分析技术有限公司 | Portable wireless glucometer |
| CN105769213A (en) * | 2016-05-11 | 2016-07-20 | 鼎泰生物科技（海南）有限公司 | Temperature compensation method and device for glucometer testing data |
| CN106597859A (en) * | 2015-10-16 | 2017-04-26 | 深圳市前海堃元智慧有限公司 | Home smart healthy ecology environment control system |
| CN107608293A (en) * | 2017-10-12 | 2018-01-19 | 广东小天才科技有限公司 | A kind of method and wearable device of intelligent control ventilation |
| CN107802255A (en) * | 2017-11-30 | 2018-03-16 | 杭州电子科技大学 | A kind of blood glucose level data processing method and processing device based on metabolic method |
| WO2018169374A1 (en) * | 2017-03-17 | 2018-09-20 | 삼성전자 주식회사 | Electronic device and control method therefor |
| CN208837957U (en) * | 2017-11-27 | 2019-05-10 | 陆云江 | A kind of blood-sugar detecting instrument of adaptive environment temperature |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8676284B2 (en) * | 2010-10-15 | 2014-03-18 | Novanex, Inc. | Method for non-invasive blood glucose monitoring |
-
2021
- 2021-06-08 CN CN202110638034.3A patent/CN113367692B/en active Active
Patent Citations (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2005110222A1 (en) * | 2004-05-18 | 2005-11-24 | Okto Medical Appliance Co., Ltd. | Blood sugar control system and medical treatment method using the same |
| CN1775174A (en) * | 2005-11-28 | 2006-05-24 | 何宗彦 | Non-wound rapid blood sugar detecting method and its detecting instrument |
| KR101320555B1 (en) * | 2012-05-09 | 2013-11-06 | (주)세종바이오테크놀로지 | System for measuring blood sugar level |
| CN203455308U (en) * | 2013-07-29 | 2014-02-26 | 深圳市倍泰健康测量分析技术有限公司 | Portable wireless glucometer |
| CN106597859A (en) * | 2015-10-16 | 2017-04-26 | 深圳市前海堃元智慧有限公司 | Home smart healthy ecology environment control system |
| CN105769213A (en) * | 2016-05-11 | 2016-07-20 | 鼎泰生物科技（海南）有限公司 | Temperature compensation method and device for glucometer testing data |
| WO2018169374A1 (en) * | 2017-03-17 | 2018-09-20 | 삼성전자 주식회사 | Electronic device and control method therefor |
| CN107608293A (en) * | 2017-10-12 | 2018-01-19 | 广东小天才科技有限公司 | A kind of method and wearable device of intelligent control ventilation |
| CN208837957U (en) * | 2017-11-27 | 2019-05-10 | 陆云江 | A kind of blood-sugar detecting instrument of adaptive environment temperature |
| CN107802255A (en) * | 2017-11-30 | 2018-03-16 | 杭州电子科技大学 | A kind of blood glucose level data processing method and processing device based on metabolic method |
Also Published As
| Publication number | Publication date |
|---|---|
| CN113367692A (en) | 2021-09-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US20070287928A1 (en) | Method, user-specific performance monitor, system, and computer software product | |
| KR20160095464A (en) | Contents Recommend Apparatus For Digital Signage Using Facial Emotion Recognition Method And Method Threof | |
| CN111671408A (en) | User drinking safety monitoring method, user terminal and server | |
| CN108154866A (en) | A kind of brightness adjusts display screen system and its brightness real-time regulating method in real time | |
| CN113367692B (en) | Adjusting method, adjusting system and storage medium capable of adjusting blood sugar of user | |
| CN116339509A (en) | Control method and control device of intelligent terminal equipment | |
| US20160166200A1 (en) | Glucose monitoring system as control input to adjustable focal length lenses | |
| CN112672684A (en) | Evaluation method and device based on blood oxygen saturation, intelligent wearable device and storage medium | |
| CN115191961A (en) | Cardiopulmonary health detection method and device, wearable device and storage medium | |
| CN210630725U (en) | Shoe-pad for rehabilitation training based on high in clouds | |
| CN110974188A (en) | Health data adjusting method, terminal equipment and computer readable storage medium | |
| CN113397512B (en) | Environment adjusting method, adjusting system and storage medium thereof | |
| CN113995390B (en) | Working mode control method of wearable device, wearable device and medium | |
| KR20190134256A (en) | Apparatus, system and method for reducing stress based on real-time bio information | |
| EP2627407B1 (en) | Modification of parameter values of optical treatment apparatus | |
| CN115105720A (en) | Sleep quality improving method and device, intelligent air conditioner, system and storage medium | |
| CN111609528B (en) | Method for controlling air conditioner through neck massager and related equipment | |
| CN110197186B (en) | PPG-based illumination comfort level measurement method and system | |
| CN113368364B (en) | Skin conductance-based environment adjusting method, adjusting system and storage medium | |
| CN114259210B (en) | Sleep staging method and control system based on dynamic skin temperature | |
| KR102614602B1 (en) | Method for calibrating non invasive biometric data | |
| KR20190051540A (en) | Personalized self-stress measurement and control device using breathing relaxation training and aromatherapy | |
| CN116897264B (en) | Environment control system, environment control device, and environment control method | |
| CN114795163A (en) | Human body state detection method and device, terminal equipment and storage medium | |
| CN116994748A (en) | Information processing method, information processing device, electronic equipment and storage medium |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| GR01 | Patent grant | ||
| GR01 | Patent grant |